On February 13-14, 2023, the Centers for Medicare & Medicaid Services (CMS) convened a virtual panel of the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) to evaluate changes to ...
For drugs where net prices of comparators are below the ceiling negotiated price, we recommend that CMS follow a value-based pricing approach that can set the stage for a transparent negotiation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results